SXI Life Sciences
6.967,62
PKT
-8,28
PKT
-0,12
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.12.20 | Roche overweight | JP Morgan Chase & Co. | |
| 27.11.20 | Novartis Underweight | Barclays Capital | |
| 25.11.20 | Novartis buy | UBS AG | |
| 25.11.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.11.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.11.20 | Roche buy | UBS AG | |
| 10.11.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.11.20 | Roche overweight | JP Morgan Chase & Co. | |
| 02.11.20 | Novartis buy | UBS AG | |
| 29.10.20 | Roche buy | UBS AG | |
| 28.10.20 | Novartis Neutral | Credit Suisse Group | |
| 27.10.20 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.10.20 | Roche overweight | Barclays Capital | |
| 27.10.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.10.20 | Novartis Underweight | Barclays Capital | |
| 27.10.20 | Novartis buy | Jefferies & Company Inc. | |
| 23.10.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.10.20 | Novartis overweight | Morgan Stanley | |
| 19.10.20 | Roche overweight | JP Morgan Chase & Co. | |
| 16.10.20 | Roche buy | UBS AG | |
| 16.10.20 | Roche Outperform | Bernstein Research | |
| 16.10.20 | Roche Neutral | Credit Suisse Group | |
| 15.10.20 | Roche Hold | Kepler Cheuvreux | |
| 15.10.20 | Roche buy | UBS AG | |
| 15.10.20 | Roche buy | Jefferies & Company Inc. | |
| 15.10.20 | Roche Outperform | Bernstein Research | |
| 15.10.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.10.20 | Roche overweight | JP Morgan Chase & Co. | |
| 14.10.20 | Novartis buy | UBS AG | |
| 13.10.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.10.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.10.20 | Roche Neutral | Credit Suisse Group | |
| 01.10.20 | Roche buy | Jefferies & Company Inc. | |
| 30.09.20 | Roche buy | UBS AG | |
| 30.09.20 | Roche buy | Jefferies & Company Inc. | |
| 30.09.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 29.09.20 | Roche overweight | JP Morgan Chase & Co. | |
| 29.09.20 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.09.20 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.09.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. |